S. 27, The Preserve Access to Affordable Generics Act

• This item is from the 112th Congress (2011-2012) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.
• This bill, or a similar bill, was reintroduced in the current Congress as S. 214, The Preserve Access to Affordable Generics Act.

Version saved on July 23, 2011, 07:03:46, by webmaster:

S. 27 would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.

Detailed Summary

(Log in to edit the wiki and be the first to provide a detailed summary of the bill!)

Status of the Legislation

Latest Major Action: 7/22/2011: Placed on Senate Legislative Calendar under General Orders. Calendar No. 110.

Points in Favor

(Log in to edit the wiki and be the first to show why the bill should pass!)

Points Against

(Log in to edit the wiki and be the first to show why the bill should not pass!)

« Return to Revision History.